Back to search

Peptide record

TPDB41274

IL13Rα2 D1 peptide Anticancer standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41274
IL13Rα2 D1 peptide
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 12-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
GSETWKTIITKN
Physicochemical Analysis
C61H100N16O20
ARDCQHLMFPYV
T
1377.56
9.88
2
1
3
+1
2.51
-0.833
65.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5500
399.26
5
Residue Composition
number
0
A
0
R
1
N
0
D
0
C
1
E
0
Q
1
G
0
H
2
I
0
L
2
K
0
M
0
F
0
P
1
S
3
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 0 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 2 L: 0 K: 2 M: 0 F: 0 P: 0 S: 1 T: 3 W: 1 Y: 0 V: 0
Chemical Descriptors
12
C61H100N16O20
1377.56
9.88
+1
2.51
-0.833
Free
L
Linear
Free
Anticancer
Synthetic
Evidence Records 4 records
Evidence 1 Activity

Activity

inhibited IL13-stimulated cell adhesion
Anticancer

Target

Colorectal Cancer
KM12SM
Colon

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

inhibited IL13-stimulated cell adhesion
Anticancer

Target

Colorectal Cancer
SW-620
Colon

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018
Evidence 3 Activity

Activity

inhibited IL13-stimulated cell adhesion
Anticancer

Target

Brain Cancer
U-87
Brain

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018
Evidence 4 Activity

Activity

inhibited IL13-stimulated cell adhesion
Anticancer

Target

Brain Cancer
U-118
Brain

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018